Live feed
Filing
SC 13D/A
SC 13D/A0001193125-18-215834·LFB Biotechnologies S.A.S.U.
Schedule 13D ownership disclosure
TG THERAPEUTICS INC COM
Security class unavailable · CUSIP: 88322Q108
Event date: 2018-07-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-215834
- Form type
- SC 13D/A
- Filer
- LFB Biotechnologies S.A.S.U.
- CIK
- CIK 1377942
- Filed
- Jul 11, 2018
- Reporting period
- Jul 06, 2018
- Description
- Schedule 13D beneficial ownership